Morgan Stanley
GTBP icon

Morgan Stanley’s GT Biopharma GTBP Stock Holding History

Morgan Stanley’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.77K Sell
16,599
-2,000
-11% -$1.09K ﹤0.01% 7063
2025
Q4 		$14.6K Buy
18,599
+4,584
+33% +$3.26K ﹤0.01% 6795
2025
Q3 		$8.22K Buy
14,015
+10,000
+249% +$14.9K ﹤0.01% 6955
2025
Q2 		$14.4K Buy
4,015
+482
+14% +$1.25K ﹤0.01% 6757
2025
Q1 		$7.6K Hold
3,533
– – ﹤0.01% 6884
2024
Q4 		$10.8K Buy
3,533
+3,267
+1,228% +$8.84K ﹤0.01% 6777
2024
Q3 		$614 Hold
266
– – ﹤0.01% 7278
2024
Q2 		$753 Hold
266
– – ﹤0.01% 7188
2024
Q1 		$1.18K Sell
266
-273
-51% -$1.44K ﹤0.01% 7151
2023
Q4 		$4.12K Buy
539
+270
+100% +$1.97K ﹤0.01% 7035
2023
Q3 		$1.95K Hold
269
– – ﹤0.01% 7137
2023
Q2 		$2.52K Hold
269
– – ﹤0.01% 7142
2023
Q1 		$4.44K Buy
269
+9
+3% +$206 ﹤0.01% 7080
2022
Q4 		$6.92K Buy
260
+141
+118% +$7.04K ﹤0.01% 7060
2022
Q3 		$5K Sell
119
-4,349
-97% -$333K ﹤0.01% 7251
2022
Q2 		$400K Sell
4,468
-4,429
-50% -$336K ﹤0.01% 5530
2022
Q1 		$768K Sell
8,897
-5,863
-40% -$517K ﹤0.01% 5151
2021
Q4 		$1.35M Buy
14,760
+6,350
+76% +$950K ﹤0.01% 4866
2021
Q3 		$1.7M Buy
8,410
+7,249
+624% +$2.18M ﹤0.01% 4698
2021
Q2 		$540K Buy
1,161
+1,074
+1,234% +$446K ﹤0.01% 5476
2021
Q1 		$18K Buy
+87
New +$15.2K ﹤0.01% 6755

Other funds holding GTBP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
I
INVST Indianapolis, Indiana $886M AUM 21.79% 1-Year Est. Return

Morgan Stanley's GTBP Position: Q1 2026 in Review

Morgan Stanley reduced its GT Biopharma (GTBP) stake by 11% in Q1 2026, selling an estimated $1.09K and leaving 16,599 shares worth $6.77K. The position accounts for ﹤0.01% of the portfolio, ranked #7063.

Morgan Stanley first reported a position in GTBP in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.7M in Q3 2021. 42 funds tracked by Wall St. Rank hold GTBP as of Q1 2026.

  • Morgan Stanley held 16,599 shares of GT Biopharma worth $6.77K as of Q1 2026.
  • Morgan Stanley sold 2,000 GT Biopharma shares in Q1 2026, an estimated $1.09K.
  • GT Biopharma made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7063 holding.
  • Morgan Stanley first reported a position in GT Biopharma in Q1 2021 and has held it in 21 quarters since.
  • Morgan Stanley's GT Biopharma position peaked at $1.7M in Q3 2021.
  • 42 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.